Brainstorm Cell Therapeutics Inc. - Common Stock (NQ:BCLI)

1.170 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Brainstorm Cell Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 28, 2023

Via Benzinga

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation – BCLI

September 28, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

Nasdaq Rises Over 100 Points; Accenture Shares Fall After Q4 Results ↗

September 28, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Thursday. The Dow traded up 0.40% to 33,683.43 while the NASDAQ rose 0.95% to 13,217.46. The S&P 500...

Via Benzinga

Topics Stocks

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 28, 2023

Via Benzinga

Brainstorm Cell's Earnings: A Preview ↗

August 11, 2023

Via Benzinga

Brainstorm Cell's Earnings Outlook ↗

May 12, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 28, 2023

Via Benzinga

Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 28, 2023

Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...

Via Benzinga

Crude Oil Moves Lower; CarMax Posts Downbeat Earnings ↗

September 28, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining 1% on Thursday. The Dow traded up 0.58% to 33,745.23 while the NASDAQ rose 1% to 13,223.61. The S&P 500 also rose,...

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 ↗

September 28, 2023

Via Benzinga

Dow Rises 80 Points; US Jobless Claims Edge Higher ↗

September 28, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 80 points on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 33,630.52 while the NASDAQ rose 0.12%...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 28, 2023

Via Benzinga

FDA Advisory Panels Gives Thumbs Down To BrainStorm's Lead Therapy ↗

September 28, 2023

The FDA's Cellular, Tissue and Gene Therapies Advisory Committee meeting reviewing BrainStorm Cell Therapeutics Inc's (NASDAQ: BCLI) NurOwn application voted that NurOwn did not demonstrate substantial...

Via Benzinga

Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket ↗

September 27, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 25, 2023

Via Benzinga

Gold Moves Lower; TransCode Therapeutics Shares Surge ↗

September 25, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 25, 2023

Via Benzinga

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 25, 2023

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

Via Benzinga

Nasdaq Turns Higher; SCYNEXIS Shares Plunge ↗

September 25, 2023

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded down 0.01% to 33,962.53 while the NASDAQ rose 0.26% to 13,246.15. The S&P 500...

Via Benzinga

Topics Stocks

Why Is Neurodegenerative Disease-Focused Brainstorm Cell Therapeutics Stock Plunging Today? ↗

September 25, 2023

Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) shares are sinking after the FDA released briefing documents ahead of the adcomm meeting scheduled on

Via Benzinga

U.S. Stocks Open Lower; Chicago Fed Index Falls In August ↗

September 25, 2023

U.S. stocks traded mostly lower this morning, with the Dow Jones trading falling around 80 points on Monday. Following the market opening Monday, the Dow traded down 0.26% to 33,875.83 while the NASDAQ...

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 25, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

September 25, 2023

It's time for another dive into the biggest pre-market stock movers as we check out all of the latest news on Monday morning!

Via InvestorPlace

Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved" ↗

September 14, 2023

BioRestorative Therapies Inc. (NASDAQ: BRTX) (“BioRestorative”) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions...

Via Benzinga

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Quarter ↗

July 27, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

BrainStorm Cell Therapeutics Shares Fall After Updated Biomarker Data From Lead Cell Therapy Candidate ↗

July 07, 2023

BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) presented new biomarker data from the Phase 3 trial of its late-stage investigational amyotrophic lateral sclerosis (ALS) treatment, NurOwn, at the 2023...

Via Benzinga

BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities ↗

July 06, 2023

BioRestorative Therapies Inc. (NASDAQ: BRTX) has received a unanimous recommendation to proceed in its Phase 2 clinical trial for chronic lumb

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 31, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.